GlassScriptPhysician profile
Gostal Arcelin
NPI 1306832357
$2,854.19
in general payments reported to CMS, 2019-2025
37 companies · $735 in 2025
The $735 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $196 · 2021: $448 · 2022: $614 · 2023: $339 · 2024: $314 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,388.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $474.19 | 2019-2025 | Lo Loestrin Fe, Orilissa, Oriahnn |
| Intuitive Surgical, INC. | $310.66 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $269.98 | 2019-2025 | |
| Coopersurgical, INC. | $179.86 | 2021-2025 | Summit Doppler |
| Biogen, INC. | $165.69 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $163.55 | 2019-2025 | Thinprep 2000 Processor, Aptima, Myosure Tissue Removal Device |
| Myovant Sciences INC. | $132.13 | 2021-2022 | |
| Baxter Healthcare | $102.17 | 2025 | Perclot |
| Organon LLC | $80.78 | 2025 | |
| Radiometer America, INC | $80.58 | 2024 | |
| Astellas Pharma US INC | $75.33 | 2025 | Veozah |
| Exeltis, USA INC. | $71.05 | 2019-2023 | Slynd |
| Exact Sciences Corporation | $68.38 | 2023-2025 | Cologuard Collection Kit |
| Millicent US INC | $62.34 | 2019-2025 | Intrarosa, Femring |
| Mayne Pharma Commercial LLC | $59.97 | 2022-2023 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $59.18 | 2023-2025 | Myfembree |
| Mylan Pharmaceuticals INC. | $40.35 | 2021 | |
| Allergan, INC. | $36.26 | 2019-2020 | |
| Ethicon US, LLC | $35.58 | 2020 | |
| Pfizer INC. | $35.22 | 2023-2024 | |
| Amgen INC. | $30.59 | 2019-2023 | Evenity, Prolia |
| Novo Nordisk INC | $30.53 | 2021-2025 | |
| Sanofi Pasteur INC. | $28.34 | 2025 | |
| Momentis Surgical INC. | $28.00 | 2022 | |
| Lupin INC. | $25.71 | 2019-2021 | |
| Avion Pharmaceuticals | $24.78 | 2020-2021 | |
| Lilly USA, LLC | $21.97 | 2023 | Jardiance |
| Scynexis, INC. | $20.04 | 2022 | |
| Meditrina | $18.16 | 2021 | |
| Therapeuticsmd, INC. | $17.72 | 2020 | |
| Duchesnay USA Incorporated | $17.36 | 2019 | |
| Mission Pharmacal Company | $16.88 | 2022 | |
| Agile Therapeutics, INC. | $14.85 | 2022 | |
| Amag Pharmaceuticals, INC. | $14.82 | 2019 | |
| Glaxosmithkline, LLC. | $14.10 | 2019 | |
| Medicem INC. | $13.71 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $13.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gostal Arcelin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.